OLVIG
RXDX

Oliver Lagore Vanvalin Investment Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-47
Closed -$5.04K – 850
2023
Q1 		$5.04K Buy
47
+6
+15% +$644 ﹤0.01% 478
2022
Q4 		$4.51K Buy
+41
New +$4.51K ﹤0.01% 475